+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Self-injections Market Research Report by Type, by Application, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4985960
  • Report
  • July 2021
  • Region: Global
  • 187 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Self-injections Market will Grow to USD 68.99 Billion by 2026, at a CAGR of 10.94%

FEATURED COMPANIES

  • 3M Company
  • Baxter International Inc.
  • Eli Lilly and Company
  • Owen Mumford Ltd
  • PharmaJet, Inc.
  • SHL Group
The Global Self-injections Market size was estimated at USD 36.98 Billion in 2020 and expected to reach USD 40.91 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 10.94% to reach USD 68.99 Billion by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Self-injections to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the Self-injections Market was studied across Auto-Injectors, Needle-free Injectors, Pen Injectors, and Wearable Injectors.
  • Based on Usage, the Self-injections Market was studied across Disposable and Reusable.
  • Based on Application, the Self-injections Market was studied across Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, and Respiratory Therapy.
  • Based on Distribution Channel, the Self-injections Market was studied across Hospital Pharmacies, Online Pharmacies, and Private Clinics.
  • Based on Region, the Self-injections Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Self-injections Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Self-injections Market, including 3M Company, Abbvie Inc., Antares Pharma, Inc., Baxter International Inc., Becton, Dickinson and Company, Bespak Europe Ltd., Credence MedSystems, Inc., Eli Lilly and Company, Gerresheimer AG, Insulet Corporation, Owen Mumford Ltd, Penjet Corporation, Pfizer Inc., PharmaJet, Inc., Recipharm AB, SCHOTT AG, SHL Group, Sulzer AG, Terumo Corporation, West Pharmaceutical Services, Inc., Wilhelm Haselmeier GmbH & Co. KG, and Ypsomed AG.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Self-injections Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Self-injections Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Self-injections Market?
4. What is the competitive strategic window for opportunities in the Global Self-injections Market?
5. What are the technology trends and regulatory frameworks in the Global Self-injections Market?
6. What is the market share of the leading vendors in the Global Self-injections Market?
7. What modes and strategic moves are considered suitable for entering the Global Self-injections Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • Baxter International Inc.
  • Eli Lilly and Company
  • Owen Mumford Ltd
  • PharmaJet, Inc.
  • SHL Group
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Usage Outlook
3.5. Application Outlook
3.6. Distribution Channel Outlook
3.7. Region Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid prevalence of chronic diseases prominently diabetes and rheumatoid arthritis
5.1.1.2. Technological advancement acquired by pharmaceutical companies
5.1.1.3. Low cost, easy use and patent expiry of biological drugs and demand for biosimilars
5.1.2. Restraints
5.1.2.1. Strict regulation for patent approval and lack of awareness
5.1.3. Opportunities
5.1.3.1. Development of biologic drugs to treat autoimmune disease
5.1.3.2. Worldwide increase in diabetes and the growing pressure on health care costs
5.1.4. Challenges
5.1.4.1. Growing use of alternative delivery methods
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Self-injections Market, by Type
6.1. Introduction
6.2. Auto-Injectors
6.3. Needle-free Injectors
6.4. Pen Injectors
6.5. Wearable Injectors

7. Self-injections Market, by Usage
7.1. Introduction
7.2. Disposable
7.3. Reusable

8. Self-injections Market, by Application
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Hormonal Disorders
8.4. Orphan Diseases
8.5. Respiratory Therapy

9. Self-injections Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Private Clinics

10. Americas Self-injections Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Self-injections Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Thailand

12. Europe, Middle East & Africa Self-injections Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. 3M Company
14.2. Abbvie Inc.
14.3. Antares Pharma, Inc.
14.4. Baxter International Inc.
14.5. Becton, Dickinson and Company
14.6. Bespak Europe Ltd.
14.7. Credence MedSystems, Inc.
14.8. Eli Lilly and Company
14.9. Gerresheimer AG
14.10. Insulet Corporation
14.11. Owen Mumford Ltd
14.12. Penjet Corporation
14.13. Pfizer Inc.
14.14. PharmaJet, Inc.
14.15. Recipharm AB
14.16. SCHOTT AG
14.17. SHL Group
14.18. Sulzer AG
14.19. Terumo Corporation
14.20. West Pharmaceutical Services, Inc.
14.21. Wilhelm Haselmeier GmbH & Co. KG
14.22. Ypsomed AG

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL SELF-INJECTIONS MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2020 (USD BILLION)
FIGURE 3. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2020 (USD BILLION)
FIGURE 4. GLOBAL SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
FIGURE 5. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD BILLION)
FIGURE 6. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REGION, 2020 (USD BILLION)
FIGURE 7. GLOBAL SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 8. GLOBAL SELF-INJECTIONS MARKET: MARKET DYNAMICS
FIGURE 9. GLOBAL SELF-INJECTIONS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 10. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 11. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2026
FIGURE 13. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTO-INJECTORS, 2018-2026 (USD BILLION)
FIGURE 14. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 15. GLOBAL SELF-INJECTIONS MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2026 (USD BILLION)
FIGURE 16. GLOBAL SELF-INJECTIONS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 17. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PEN INJECTORS, 2018-2026 (USD BILLION)
FIGURE 18. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PEN INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 19. GLOBAL SELF-INJECTIONS MARKET SIZE, BY WEARABLE INJECTORS, 2018-2026 (USD BILLION)
FIGURE 20. GLOBAL SELF-INJECTIONS MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 21. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2020 VS 2026 (%)
FIGURE 22. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2020 VS 2026 (USD BILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2026
FIGURE 24. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISPOSABLE, 2018-2026 (USD BILLION)
FIGURE 25. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISPOSABLE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 26. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REUSABLE, 2018-2026 (USD BILLION)
FIGURE 27. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REUSABLE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 28. GLOBAL SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 29. GLOBAL SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2026
FIGURE 31. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2026 (USD BILLION)
FIGURE 32. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 33. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONAL DISORDERS, 2018-2026 (USD BILLION)
FIGURE 34. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 35. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ORPHAN DISEASES, 2018-2026 (USD BILLION)
FIGURE 36. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ORPHAN DISEASES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 37. GLOBAL SELF-INJECTIONS MARKET SIZE, BY RESPIRATORY THERAPY, 2018-2026 (USD BILLION)
FIGURE 38. GLOBAL SELF-INJECTIONS MARKET SIZE, BY RESPIRATORY THERAPY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 39. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
FIGURE 40. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD BILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
FIGURE 42. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD BILLION)
FIGURE 43. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 44. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2026 (USD BILLION)
FIGURE 45. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 46. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PRIVATE CLINICS, 2018-2026 (USD BILLION)
FIGURE 47. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 48. AMERICAS SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. ARGENTINA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. BRAZIL SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. CANADA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. MEXICO SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. UNITED STATES SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. AUSTRALIA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. CHINA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. INDIA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. INDONESIA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. JAPAN SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. MALAYSIA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. PHILIPPINES SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 62. SINGAPORE SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 63. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 64. THAILAND SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 66. FRANCE SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 67. GERMANY SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 68. ITALY SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 69. NETHERLANDS SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 70. QATAR SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 71. RUSSIA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 72. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 73. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 74. SPAIN SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 75. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 76. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 77. GLOBAL SELF-INJECTIONS MARKET: FPNV POSITIONING MATRIX
FIGURE 78. GLOBAL SELF-INJECTIONS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 79. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SELF-INJECTIONS MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL SELF-INJECTIONS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL SELF-INJECTIONS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL SELF-INJECTIONS MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL SELF-INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ORPHAN DISEASES, BY REGION, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL SELF-INJECTIONS MARKET SIZE, BY RESPIRATORY THERAPY, BY REGION, 2018-2026 (USD BILLION)
TABLE 17. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD BILLION)
TABLE 18. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 19. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 20. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 21. AMERICAS SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 22. ARGENTINA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 23. BRAZIL SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. CANADA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. MEXICO SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. UNITED STATES SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. AUSTRALIA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. CHINA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. INDIA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. INDONESIA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. JAPAN SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. MALAYSIA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. PHILIPPINES SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. SINGAPORE SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. THAILAND SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. FRANCE SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. GERMANY SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. ITALY SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. NETHERLANDS SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. QATAR SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. RUSSIA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 47. SPAIN SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 48. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 49. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 50. GLOBAL SELF-INJECTIONS MARKET: SCORES
TABLE 51. GLOBAL SELF-INJECTIONS MARKET: BUSINESS STRATEGY
TABLE 52. GLOBAL SELF-INJECTIONS MARKET: PRODUCT SATISFACTION
TABLE 53. GLOBAL SELF-INJECTIONS MARKET: RANKING
TABLE 54. GLOBAL SELF-INJECTIONS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 55. GLOBAL SELF-INJECTIONS MARKET: MERGER & ACQUISITION
TABLE 56. GLOBAL SELF-INJECTIONS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 57. GLOBAL SELF-INJECTIONS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 58. GLOBAL SELF-INJECTIONS MARKET: INVESTMENT & FUNDING
TABLE 59. GLOBAL SELF-INJECTIONS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 60. GLOBAL SELF-INJECTIONS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • 3M Company
  • Abbvie Inc.
  • Antares Pharma, Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Bespak Europe Ltd.
  • Credence MedSystems, Inc.
  • Eli Lilly and Company
  • Gerresheimer AG
  • Insulet Corporation
  • Owen Mumford Ltd
  • Penjet Corporation
  • Pfizer Inc.
  • PharmaJet, Inc.
  • Recipharm AB
  • SCHOTT AG
  • SHL Group
  • Sulzer AG
  • Terumo Corporation
  • West Pharmaceutical Services, Inc.
  • Wilhelm Haselmeier GmbH & Co. KG
  • Ypsomed AG
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll